TGM2 and chronic myelogenous leukemia, BCR-ABL1 positive: A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia